Prescriber's Letter

Commentary: Ondansetron in Pregnancy—Is it Safe? January 2014

Commentary: FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions January 2014

PL Voices: New Cholesterol Guidelines for Lowering Cardiovascular Risk January 2014

Guideline: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults January 2014

Commentary: Calcium Channel Blocker-Macrolide Interaction January 2014

PL Voices: Controversy About the New Cardiovascular Risk Calculator January 2014

Chart: Meds and Choosing Wisely January 2014

Article: new ACC/AHA cholesterol guidelines that focus MORE on statins...LESS on non-statins...and ABANDON LDL goals January 2014

Article: New lifestyle and obesity guidelines will help patients with New Year's resolutions to improve health and lower cardiovascular risk January 2014

Article: The Avandia (rosiglitazone) debate will heat up again now that FDA will loosen its restrictions January 2014

Article: controversy about the NEW cardiovascular risk calculator January 2014

Article: Endocrinologists are now releasing their own Choosing Wisely list of top practices to question when treating endocrine disorders January 2014

Article: using ondansetron for morning sickness January 2014

Article: kidney problems when clarithromycin is combined with a calcium channel blocker (amlodipine, etc) January 2014

Article: controversy about what works to prevent contrast-induced nephropathy December 2013

Cardiology